Vajda FJ, Bladin PF, Parsons BJ. 1985. Clinical experience with clobazam: a new 1,5 benzodiazepine in the treatment of refractory epilepsy. Clin Exp Neurol, 21:177–82. van Engelen BG, Renier WO, Weemaes CM, et al. 1994a. High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox- Gastaut syndrome: an add-on study. Eur J Pediatr, 153:762–9. van Engelen BG, Renier WO, Weemaes CMR, et al. 1994b. Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Research, 19:181–90. van Rijckevorsel K, Delire M, Rucquoy-Ponsar M. 1986. Treatment of idiopathic West and Lennox-Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins. Eur Arch Psych Clin Neuroscience, 236:119–22. van Rijckevorsel K, Delire M, Schmitz-Moorman W, et al. 1994. Treatment of refractory epilepsy with intraveinous immunoglobulins. Results of the ﬁrst double blind/dose ﬁnding clinical study. Intern J Clin Lab Res, 24:162–6. van Rijckevorsel K. 1999. Immunological mechanisms in the aetiology of epilepsy. Implications for treatment. Biodrugs, 12:115–27. van Rijckevorsel K, de Tourtchaninoff M, van Raay Y, et al. 2006. Multiple subpial transsections: safety and evolution of 30 patients. Epilepsia, 47(S3):4–5. Van Wagenen WP, Herren RY. 1940. Surgical division of commissural pathways and the corpus callosum: relation to spread of an epileptic attack. Arch Neurol Psychiatry, 44:740–59. Vassella F, Pavlincova E, Schneider HJ, et al. 1973. Treatment of infantile spasms and Lennox-Gastaut syndrome with clonazepam (Rivotril). Epilepsia, 14:165–75. Vassella F, Rudeberg A, Da Silva V, et al. 1978. Double-blind study of the anticonvulsive effect of Phenobarbital and valproate in the Lennox syndrome. (Doppelblind Untersuchung uber die anticonvulsive Wirkung von Phenobarbital and Valproat beim Lennox-Gastaut Syndrom). Schweiz Med Wochenschr, 108:713–6. Vaz G, van Raay Y, van Rijckevorsel K, et al. 2008. [Safety and efﬁcacy of multiple subpial transections: report of a consecutive series of 30 cases]. Neurochirurgie, 54:311–4. Velasco M, Velasco F, Alcala H, et al. 1991. Epileptiform EEG activity of the centromedian thalamic nuclei in children with intractable generalized seizures of the Lennox-Gastaut syndrome. Epilepsia, 32:310–21. Velasco F, Velasco M, Velasco AL, et al.1993. Effect of chronic electrical stimulation of the centromedian thalamic nuclei on various intractable seizure patterns, I: clinical seizures and paroxysmal EEG activity. Epilepsia, 34:1052–64. Velasco AL, Velasco F, Jimenez F, et al. 2006. Neuromodulation of the centromedian thalamic nuclei in the treatment of generalized seizures and the improvement of the quality of life in patients with Lennox-Gastaut syndrome. Epilepsia, 47:1203–12. Verhelst H, Boon P, Buyse G, et al. 2005. Steroids in intractable childhood epilepsy: clinical experience and review of the literature. Seizure, 14:412–21. Lennox-Gastaut treatment Vining EP, Freeman JM, Ballaban-Gil K, et al. 1998.A multicenter study of the efﬁcacy of the ketogenic diet. Arch Neurol, 55:1433–7. von Rosenstiel P. 2007. Brivaracetam (UCB 34714). Neurotherapeutics, 4:84–7. Vossler DG. 1996. Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin. Neurology, 46:852–3. Wang D, Pascual JM, Engelstad K, et al. 2005. Glut-1 deﬁciency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol, 57:111–8. Weber S, Beran RG. 2004. A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy. J Clin Neurosci, 11:728–31. Wexler ID, Hemalatha SG, Mc Connell J, et al. 1997. Outcome of pyruvate dehydrogenase deﬁciency treated with ketogenic diets. Studies in patients with identical mutations. Neurology, 49:1655–61. Wheless JW, Clarke DF, Carpenter D. 2005. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol, 20(S1):S1–S56. White HS, Smith MD, Wilcox KS. 2007. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol, 81:85–110. Woody RC. 1990. Bromide therapy for pediatric seizure disorder intractable to other antiepileptic drugs. J Child Neurol, 5:65–7. Wyllie E, Lachhwani DK, Gupta A, et al. 2007. Successful surgery for epilepsy due to early brain lesions despite generalized EEG ﬁndings. Neurology, 69:389–97. Xu X, Müller-Taubenberger A, Adley KE, et al. 2007. Attenuation of Phospholipid Signaling Provides a Novel Mechanism for the Action of Valproic Acid. Eukariotic Cell, 6:899–906. Yagi K. 2004. Overview of Japanese experience, controlled and uncontrolled trials. Seizure, 13(S):S11–S15 Yamatogi Y, Ohtsuka Y, Ishida T, et al. 1979. Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain Dev, 1:267–76. Yamatogi Y, Ohtahara S. 2006. Multiple independent spike foci and epilepsy, with special reference to a new epileptic syndrome of “severe epilepsy with multiple independent spike foci”. Epilepsy Res, 70(S1):S96–S104. Yildirim M, Marangoz C. 2006. Anticonvulsant effects of melatonin on peni- cillin-induced epileptiform activity in rats. Brain Res, 12,1099:183–8. You SJ, Lee JK, Ko TS. 2007b. Epilepsy surgery in a patient with Lennox- Gastaut syndrome and cortical dysplasia. Brain Dev, 29:167–70. You SJ, Kang HC, Ko TS, et al. 2007c. Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome. Brain Dev, 30:195–9. You SJ, Kang HC, Kim HD, et al. 2008a. Clinical efﬁcacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience. Brain Dev, 30:287–90. You SJ , Jung DE, Kim HD, et al. 2008b. Efﬁcacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy. Eur J Paediatr Neurol, 12:314–20. Zhao Q, Tian Z, Liu Z, et al. 2003. Evaluation of the combination of multiple subpial transection and other techniques for treatment of intractable epilepsy. Chin Med J (Engl), 116:1004–7. Neuropsychiatric Disease and Treatment 2008:4(6) 1019